282 related articles for article (PubMed ID: 36819342)
1. Hereditary Angioedema with Normal C1 Esterase Inhibitor Refractory to Long-Term Prophylaxis: A Case Report.
Cobb G; Bernabe CC
Cureus; 2023 Jan; 15(1):e33800. PubMed ID: 36819342
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data.
Johnson F; Stenzl A; Hofauer B; Heppt H; Ebert EV; Wollenberg B; Lochbaum R; Hahn J; Greve J; Trainotti S
Clin Rev Allergy Immunol; 2023 Dec; 65(3):354-364. PubMed ID: 37914894
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor.
Jones DH; Bansal P; Bernstein JA; Fatteh S; Harper J; Hsu FI; O'Connor M; Park N; Suez D
World Allergy Organ J; 2022 Jan; 15(1):100621. PubMed ID: 35145604
[TBL] [Abstract][Full Text] [Related]
4. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
5. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
6. The Genetics of Hereditary Angioedema: A Review.
Santacroce R; D'Andrea G; Maffione AB; Margaglione M; d'Apolito M
J Clin Med; 2021 May; 10(9):. PubMed ID: 34065094
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor.
Gabriel N; Marcelino F; Ferriani MPL; Arruda LK; Campos RA; Gonçalves RF; Chong-Neto H; Rosario Filho N; Valle SOR; Pesquero JB; Grumach AS
Front Allergy; 2022; 3():846968. PubMed ID: 35386641
[TBL] [Abstract][Full Text] [Related]
8. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
Henry Li H; Riedl M; Kashkin J
Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
Valerieva A; Staevska MT; Grivcheva-Panovska V; Jesenak M; Kőhalmi KV; Hrubiskova K; Zanichelli A; Bellizzi L; Relan A; Hakl R; Farkas H
World Allergy Organ J; 2021 Apr; 14(4):100535. PubMed ID: 33995818
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
Valerieva A; Caccia S; Cicardi M
Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
[TBL] [Abstract][Full Text] [Related]
11. A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable.
Longhurst HJ; Valerieva A
J Asthma Allergy; 2023; 16():269-277. PubMed ID: 36922963
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Hereditary Angioedema.
Caballero T
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
[TBL] [Abstract][Full Text] [Related]
13. Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety.
Lunn M; Santos C; Craig T
J Blood Med; 2010; 1():163-70. PubMed ID: 22282695
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
[TBL] [Abstract][Full Text] [Related]
15. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
16. Hereditary and acquired angioedema.
Patel G; Pongracic JA
Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hereditary angioedema-single or multiple pathways to the rescue.
Valerieva A; Longhurst HJ
Front Allergy; 2022; 3():952233. PubMed ID: 36172291
[TBL] [Abstract][Full Text] [Related]
18. Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study.
Grumach AS; Henriques MT; Bardou MLD; Pontarolli DA; Botha J; Correa M;
An Bras Dermatol; 2022; 97(4):448-457. PubMed ID: 35654647
[TBL] [Abstract][Full Text] [Related]
19. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
Bork K
Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
[TBL] [Abstract][Full Text] [Related]
20. Clinical Experience with Berotralstat in Patients with Hereditary Angioedema with Normal C1-Esterase Inhibitor: A Commented Case Series.
Kanarek HJ; Mutschelknaus DAS
J Asthma Allergy; 2024; 17():123-132. PubMed ID: 38415051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
